Pioneers in research that has led to better health and medicine world-wide, Weizmann has a long list of achievements.
A new prostate cancer drug called Tookad®, which is currently approved in Mexico for early–stage treatment, is now undergoing advanced trials in Israel and Europe, with European approval hoped for soon. The novel therapy is delivered by injection and activated using...
A new drug recently approved by the US Food and Drug Administration to treat a specific type of lung cancer, is the third cancer drug on the market that uses a Weizmann Institute of Science patent. This patent is designed to block a receptor on the surface of cells...
Anxiety effects a person’s perception, so they see the world and respond to stimuli differently, new Weizmann Institute of Science research reveals. Recently in the news, the scientific study was initially reported in the Cell Press Journal Current Biology and may...
The body’s ability to turn certain genes on and off in specific cells at a precise point in time is essential to maintaining health. This fine control in regulating particular genes is complex and involves a new class of molecules called “micro Ribonucleic Acids”...
The breakthrough cancer therapy, currently making headlines for a United States study of leukaemia patients, has its origins at the Weizmann Institute of Science, Israel. Using genetically modified T-cells from the blood, the team at the Fred Hutchinson Cancer...
For some time, the scientific world believed we had 10 times more bacteria and microbes in our bodies than human cells. But new Weizmann research, recently published in the Journal Cell, has recalculated this to reveal the ratio is actually nearer 1:1. This myth...
Infectious disease treatments can be hugely impeded if the targeted microorganisms in the body resist important drugs like antibiotics, causing serious threat to human health. Over the past two years, collaborative researchers at Flinders University, Australia and...
Following the recent discovery of an epilepsy gene called HNRNPU from a study of 500 children and adults with severe epilepsies, a joint University of Melbourne and Weizmann Institute of Research (WIS) project was funded for two years by Weizmann Australia* to...
Your weight loss diet may be failing, not because you are doing something wrong, but because your body’s metabolism is not responding as anticipated. Finally the evidence is here, revealed by Weizmann Institute of Science researchers, about something many have found...
It could be as simple as a sniff test to detect autism early in children according to new ground breaking research from the Weizmann Institute in Israel. Recently published in Current Biology, the research shows that people with autism spectrum disorder (ASD) respond...
Unfortunately, Autism Spectrum Disorder (ASD) remains a condition that presents more questions than answers. Some studies have found a lack of connection or synchronisation between different parts of the brain while other studies have found the exact opposite – an...
DIET COKE is one of science’s great miracles. Ordinary Coca-Cola relies on lashings of sugar to achieve its trademark sickly sweetness—15.9 grams per can, or about a third of the total daily intake recommended for women by Britain’s National Health Service. A can of...
Cell network mimics protein synthesis and communication of real cells, could one day be used to make products Israeli scientists have created an artificial network of cells that act like the real thing, even performing life’s most basic process — protein synthesis The...
Weizmann Institute team identifies molecule that creates the depression-relieving chemical Serotonin in the brain. Israeli scientists have identified a brain chemical, which was previously unknown, that could prove to be a breakthrough in the treatment of depression....
A new kind of genetic switch can target the activities of just one type of brain cell. Mysterious brain cells called microglia are starting to reveal their secrets thanks to research conducted at the Weizmann Institute of Science. Until recently, most of the glory in...
The race to find a cure for AIDS, one of Earth’s most pressing epidemics for more than three decades now, is often more of a chaotic relay. Thousands of international scientists must constantly revise their own projects to keep up with findings from across all...
Drug resistance, diabetes, epilepsy and protein behaviour research are set to benefit from grants worth over $(A) 0.5 million awarded by Weizmann Australia. Funded by Australian philanthropists, Weizmann Australia has established four major joint research projects...
Weizmann Institute scientists show that removing one protein from adult cells enables them to efficiently turn back the clock to a stem-cell-like state Embryonic stem cells have the enormous potential to treat and cure many medical problems. That is why the discovery...
WEIZMANN INSTITUTE SCIENTISTS DISCOVER THAT SPONTANEOUSLY EMERGING BRAIN ACTIVITY PATTERNS PRESERVE TRACES OF PREVIOUS COGNITIVE ACTIVITY REHOVOT, ISRAEL—June 25, 2013—What if experts could dig into the brain, like archaeologists, and uncover the history of past...
WEIZMANN INSTITUTE RESEARCH INTO MOUSE SOCIAL BEHAVIOR FINDS SIGNS OF LEADERSHIP AND REVEALS “AUTISTIC” MOUSE SOCIETY How does a social animal — mouse or human — gain dominance over his or her fellow creatures? A unique experiment conducted by Dr. Tali Kimchi and her...
A new Weizmann Institute study has found that if certain odours are presented after tones during sleep, people will start sniffing when they hear the tones alone – even when no odour is present – both during sleep and, later, when awake. In other words, people can...
A simple vaccine could stop the onset of autoimmune diseases such as rheumatoid arthritis and Crohn's, say scientists. The potential treatment has proved successful in animal studies and it is hoped the breakthrough could lead to new ways of tackling a range of...
The nose has long been viewed as a disorganized sensory organ, its odor receptors strewn about with very little rhyme or reason. A study in Nature Neuroscience, published online September 25, challenges that notion. It suggests that odor receptors are grouped by the...
A year ago, when chemotherapy stopped working against his leukemia, William Ludwig signed up to be the first patient treated in a bold experiment at the University of Pennsylvania. Mr. Ludwig, then 65, a retired corrections officer from Bridgeton, N.J., felt his life...